• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vaccines (Basel) . Subtype H3N2 Influenza A Viruses: An Unmet Challenge in the Western Pacific

tetano

Editor, Senior Moderator
Vaccines (Basel)


. 2022 Jan 12;10(1):112.
doi: 10.3390/vaccines10010112.
Subtype H3N2 Influenza A Viruses: An Unmet Challenge in the Western Pacific


Min Kang[SUP] 1 2 [/SUP], Mark Zanin[SUP] 3 4 [/SUP], Sook-San Wong[SUP] 3 4 [/SUP]



Affiliations

Abstract

Subtype H3N2 influenza A viruses (A(H3N2)) have been the dominant strain in some countries in the Western Pacific region since the 2009 influenza A(H1N1) pandemic. Vaccination is the most effective way to prevent influenza; however, low vaccine effectiveness has been reported in some influenza seasons, especially for A(H3N2). Antigenic mismatch introduced by egg-adaptation during vaccine production between the vaccine and circulating viral stains is one of the reasons for low vaccine effectiveness. Here we review the extent of this phenomenon, the underlying molecular mechanisms and discuss recent strategies to ameliorate this, including new vaccine platforms that may provide better protection and should be considered to reduce the impact of A(H3N2) in the Western Pacific region.

Keywords: egg-adaptation; influenza A(H3N2); novel vaccine platforms; vaccine effectiveness; western pacific.
 
Back
Top Bottom